i was posting to alan .. and expect that those who don't

New Post Public Reply Private Reply Replies (1) Message Board
4kids F1ash #35504
454
i was posting to alan .. and expect that those who don't want to read my posts
will have me on ignore as i have no doubts some do .. that said i get a lot of PMs
in from others here who might not be familiar with how *trolls* are seeded into
various SMBs *at every turn/round* .. which is why it's always so interesting to
see who *imo* outs themselves the more NRs' (non retails) *stress* is revealed

but mostly what i've always argued is that the OTC is poorly watched and almost
always manipulated .. making it far more difficult for legit companies to *outlast*
NRs' efforts .. which is why when Finra went live with this link .. i spent the month
of Feb 2010 on the phone with various employees of both the SEC and Finra

it's also why i've ALWAYS noted that it's not the one day daily reg sho %s that
matter .. it's what is shown over weeks/months and in some OTC *targeted*
survivors .. *years* .. understanding an increasing % above 30% isn't intricate
or difficult for most retail investors .. it's why what i've always posted is always
*twisted* .. when one can show (as i did in the post to alan yesterday on a very
slow day here on this SMB) .. it's crystal clear what is being done for those
willing to view aspects from another POV ..

https://investorshangout.com/post/view?id=4638682

i noted in this very venue .. numerous times .. that *stress* was in play and that
NR is struggling .. it's also why *imo* that the legal has had to *actually* adjust
upwards .. since that less than wise decision and last round

what is really telling to me is why this interpretation *threatens* .. because with
the targeted company's ability to execute .. and imo Innovation has the perfect
*set up* to force NRs' hands .. by first partnering .. then issuing a one time special
cash div .. and then almost immediately uplisting .. which keeps the *stress*
in play due to lack of liquidity .. which is artificially generated by those who do
illegally manipulate stox regardless of where *traded*

the ones i find morally repugnant are those who collude to fleece retail at every turn

what i've also always noted is there are cycles of money played out against every OTC
company and mgmt and then in turn their retail investors until *imo* NR is
upside down to such a degree the only *round* that can NR can execute
is the shake to part actual retail (vs trolls) investors out of their shares (imo
every thing done is % based) or *kill* the targeted company outright

unlike the vehicle of choice for OTC stock manipulation .. this site has unlimited
ignores .. i suggest everyone who has an issue with educating themselves
on this topic .. put me on ignore .. my feelings won't be hurt ..

lastly i've never considered the handful of posts done weekly on this topic
to be *noise* .. rather another way to view aspects *many* retail have been
conditioned against .. by those who do collude

that said .. those who do consider it noise .. should utilize features provided by this site

if you celebrate .. a safe and happy 4th

4kids

Quote:
Here's what it comes down to, for me anyway.

You both seem to be describing your concerns about a system that applies to every company listed on the same exchange as IPIX. Right?

It's safe to say everyone here has heard your concerns and protestations. Why continually harp on the matter on this board? It actually harms current shareholders more than it helps. Most investors have no clue of the intricacies you are trying to illustrate. New investors see "60% shares shorted today" and run for the freaking hills. Ever considered posting that stuff on all the other boards and not on this one. You would reach a wider audience and maybe scare some investors this way instead of running them off.

I'm not bashing you guys, hell I personally suggested Cellceutix do the name/cusip change just in case because Cellceutix was a crappy name. Cellceutix has fought lawsuits rather then just settle, they have done the name/cusip thing just in case let's give them a break please.

What you two seem insistent on doing is hurting IPIX not helping, would you mind enlightening different investors for a while on other boards. It's a big market just loaded with other stocks who could use the information you are providing.



1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Face Pressure Ahead of December 15

Updated Category News Views 3

Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...

Continue Reading
Qingdao's Food Trade Triumph at SIAL Paris Booms

Updated Category News Views 3

Qingdao Impresses in the Global Food Arena Well, 2026 is serving up something special from Qingdao. During SIAL Paris, everyone's talking about how Qingdao’s food companies smashed expectations with 82 million yuan in intended orders. You’ve got CCPIT Qingdao pulling the strings, setting up an exhibition platform that was nothing short of top-tier. Staging a Show at...

Continue Reading
Electrolux Trends: Q3 '26 Shows Resilience Amid Challenges

Updated Category News Views 3

Electrolux's Strategic Moves In A Tough Market Electrolux's Q3 2026 paints a gritty picture—yet there's a pulse of resilience underneath the numbers. Net sales bumped up to SEK 33,919m due to a 3.5% organic growth, showing the company's ability to swim through choppy waters. But let's not brush aside the sharp rocks they’re dodging: soaring raw materials and logistics...

Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

Updated Category News Views 2

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

Continue Reading
Innventure Faces Chaotic Legal Storm Over DarkNX Scandal

Updated Category News Views 1

Innventure's DarkNX Project: From Boon to Bane The stock market is no stranger to seismic shifts, but Innventure, Inc.'s recent plunge is a testament to the catastrophic impact missteps can unleash. This whole DarkNX debacle feels more like a meticulous car wreck than a business evolution. Unpacking the Allegations Sitting comfortably under the NASDAQ:INV ticker,...

Continue Reading
Lowcountry Kids to Get Free Helmets at Safety Events

Updated Category News Views 1

Helmets for Kids Initiative Gets Rolling Now, here's a story that's more about community care than cash flow, but hey, sometimes even a grizzled trader like me can nod in appreciation. Christmas Injury Lawyers are putting their money where their mouth is, with the Helmets for Kids initiative staged at two key events in the Lowcountry area. Yep, that's right—the legal...

Continue Reading
ImmunoForge Sets Sights on BIO-Europe 2026 for New Deals

Updated Category News Views 3

Making Waves with Cutting-Edge Drug Platforms Ah, how time flies in the biotech universe. Here we are, with ImmunoForge prepping to flaunt its high-tech gear at the big show in Cologne: BIO-Europe 2026. The company's aiming to gauge attention with its flashy ELP and LMT platforms, primed and ready for strategic partnerships. ELP: Revolutionizing Drug Delivery You've got...

Continue Reading
Greenberg Traurig Eyes Accolades in Middle East Awards

Updated Category News Views 3

Greenberg Traurig Aims for Middle Eastern Legal Dominance Ah, the legal world, where firms jostle like bulls in a market for the prestige of an award—it's not just about the courtroom victories, but also about snatching the right titles at glossy ceremonies. On the docket this time: Greenberg Traurig has its sights set on several prime accolades at the Law Middle East...

Continue Reading
California Contractors Honored for Safety Commitment

Updated Category News Views 9

Commitment to Safety in the Construction Industry When it comes to construction, safety isn’t an afterthought—it’s woven into the very fabric of every project. The 39th Annual Construction Safety Excellence Awards by the Associated General Contractors of California (AGC of California) pits a spotlight on those embodying this ethos. Industry Leaders in Safety Held on...

Continue Reading
Dimethylaminopropylamine Market Eyes $732M by 2035

Updated Category News Views 0

Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...

Continue Reading

Top 5 Most Recently Viewed Articles

RPA Market Set to Surge with Digital Transformation Support

Updated Category News Views 218

Understanding the Growth of the Robotic Process Automation Market The Robotic Process Automation (RPA) market is experiencing remarkable growth, with forecasts indicating an increase from USD 2.8 billion in 2023 to a staggering USD 38.4 billion by 2032. This impressive growth, at a compound annual growth rate (CAGR) of 33.8% from 2024 to 2032, reflects the growing...

Continue Reading
Unlocking Hidden Gems: Two Undervalued China Stocks to Buy

Updated Category News Views 246

Discovering Hidden Opportunities in China's Stock Market As the Chinese stock market experiences a renewed rally, discerning investors are on the lookout for undervalued companies with promising growth prospects. In a landscape dominated by major players like Alibaba and Tencent, two lesser-known stocks are gaining attention: Futu Holdings (NASDAQ: FUTU) and Atour...

Continue Reading
Exploring the Rise of Medical Spas: A Booming Industry

Updated Category News Views 186

Introduction to the Medical Spa Industry The medical spa industry is experiencing an exciting evolution, reflecting a shift in consumer preferences towards services that combine traditional spa ambiance with the expertise of medical professionals. With an increasing focus on aesthetic wellness and anti-aging solutions, we are witnessing an impressive market growth...

Continue Reading
Coherent Corp. Launches Chameleon Discovery LX Laser for Researchers

Updated Category News Views 189

Coherent Corp. Launches an Innovative Femtosecond Laser Coherent Corp. (NYSE: COHR), a renowned leader in the laser and photonics industry, has unveiled the Chameleon Discovery LX, an exciting new addition to its esteemed Chameleon Discovery product line. This revolutionary femtosecond laser is specifically designed for researchers engaged in nonlinear microscopy and...

Continue Reading
Neuronetics Shows Strong Revenue Growth Amid CEO Transition

Updated Category News Views 134

Neuronetics Reports Impressive Q3 2025 Results Neuronetics, Inc., a leader in neurohealth therapies, has shared substantial financial achievements for the third quarter of 2025. The company reported total revenues of $37.3 million, marking an significant adjusted pro forma growth of 11% compared to the same quarter in the previous year. This success can largely be...

Continue Reading